TCR2 Therapeutics Inc. announced that Mayur Somaiya informed the company of his intent to resign as Chief Financial Officer of the company to pursue a professional opportunity with a biopharmaceutical company based in New Jersey. Mr. Somaiya?s resignation will be effective immediately following his last day of service to the Company on December 10, 2021, and is not the result of any disagreement regarding the company?s financial reporting or accounting policies, procedures, estimates or judgments.